Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.115
-0.020 (-1.76%)
May 29, 2026, 4:34 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 49.03 million as of May 29, 2026. Its market cap has increased by 568.62% in one year.
Market Cap
49.03M
Enterprise Value
49.90M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.12
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 49.03M, a decrease of -85.00%. That is a compound annual growth rate of -26.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 49.03M | -23.31% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.29T |
| Genmab | 105.84B |
| Coloplast | 91.17B |
| ALK-Abelló | 58.94B |
| Gubra | 5.75B |
| BioPorto | 678.30M |
| ViroGates | 98.39M |
| Pharma Equity Group | 95.99M |